Summary
Since GHB has been detected in small amounts in the normal nervous system and it seems to be the only physiological compound which has anesthetic activity (1-3). Moreover, GHB has been known to be formed from SSA by action of an enzyme that is indistinguishable from lactic dehydrogenase (4) .
On the other hand, recent studies on the biochemical mechanism involved in the production of seizures induced by vitamin B6 antagonists indicated that changes in GABA metabolism in the brain might be involved in the etiology of the seizures (5, 6) .
Since both SSA and GHB are compounds related metabolically to GABA (7, 8) , it seems reasonable to investigate the actions of SSA and GHB on the seizures caused by vitamin B6 antagonists, and this was studied in the present paper. The B6 antagonists used in this experiment are castrix, thiosemicarbazide and penicillamine.
MATERIALS
SSA was prepared by the method of Bessman et al. (8) . GHB was pur chased from Sigma Chemical Company. Castrix was kindly supplied by Mr. Effect of SSA on seizure produced by penicillamine According to MATSUDA and MAKINO (10), animals were injected subcutane ously with 0.35mg/g DL-penicillamine. At 160min after the injection, SSA or saline as control was injected intraperitoneally as described in the castrix experi ment. When the penicillamine-treated animals were subsequently given SSA, the seizure was completely prevented and the animals were saved from death (Fig.  2) . The preventive action of SSA was effective even after the first occurrence of the seizure. Effect of SSA on seizure produced by thiosemicarbazide In the experiment in our laboratory (11), animals were injected subcutane ously with 0.02mg/g thiosemicarbazide. At that time, as shown in Fig. 3 , SSA or saline was injected intraperitoneally. Injection of SSA completely prevented all the test animals receiving thiosemicarbazide from seizures for about 150min after this injection, though after 150min the seizures took place; the occurrence rate of seizures was 3/4 and mortality 2/4 (Fig. 3) . Even after the first occurrence of the seizure the injection of SSA prevented all animals from the subsequent 
DISCUSSION
In this paper the effect of SSA and GHB on the convulsive action of B6 antago nists, such as castrix, thiosemicarbazide and penicillamine was studied , using the onset of seizure (running fit and convulsion) as a parameter. And it was found that the administration of GHB is able to delay the onset of the convulsions pro duced by the B6 antagonists, and SSA in many cases completely prevents the convulsions. The anticonvulsant effect of SSA seems to be due to an increase in brain levels of GHB converted from SSA, because the action of GHB appears at lower dose and earlier than with SSA.
The seizures induced by the B6 antagonists have been well known to be completely suppressed by the administration of vitamin B6 (10, 12, 13) . Both glutamic decarboxylase and GABA transaminase involving in GABA metabolism are vitamin B6 dependent enzymes, and the glutamic decarboxylase activity is particularly affected by vitamin B6 deficiency (6) . Therefore, to the extent that the seizures induced by B6 antagonists do lead to a lowering of the levels of GABA metabolism, it seems reasonable that the levels of SSA and consequently GHB , two possible metabolites of GABA, may also be lowered.
If it can be postulated that a decrease in the brain levels of GHB is an im portant factor in the production of convulsion, the above evidences would also seem logical that the administration of GHB or SSA is able to delay the onset of the convulsions, or in some cases completely prevents the convulsions. However, no evidence has been demonstrated yet that SSA or GHB paly a role in normal neuronal functioning and that there is actually a decrease in amounts of SSA or GHB during convulsions, because the level of endogenous GHB is order of magnitude lower than effective concentrations in the brain following and I. KAWAMATA intraperitoneal administration (3) and the concentration of endogenous SSA is below the limits of known method of analysis. Therefore, the fact that GHB or SSA may alter the course of the convulsions may not be taken as evidence that the convulsions are caused by depleted endogenous levels of these compounds.
It seems possible that the administration of SSA or GHB might do more than refill the depleted endogenous stores; the drags may be exerting a "pharma cological" effect other than "biochemical" effect on neuronal excitability.
